Clinical Research Directory
Browse clinical research sites, groups, and studies.
PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation
Sponsor: Yale University
Summary
This prospective randomized pilot study evaluates the feasibility, acceptability, and preliminary efficacy of the Patient-Controlled Dispenser and Deactivator (PCDD) Generation 1 system for patient-controlled oral liquid acetaminophen administration in postoperative total shoulder replacement inpatients compared with standard nurse-administered oral acetaminophen delivery.
Official title: Evaluation of the Patient-Controlled Dispenser & Deactivator (PCDD) Generation 1 System for Oral Liquid Acetaminophen Delivery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-09
Completion Date
2027-12
Last Updated
2026-09-03
Healthy Volunteers
No
Conditions
Interventions
PCDD Generation 1 system
Dispenses prescribed oral liquid medication through a secure, patient-activated mechanism . The system provides access to as needed oral liquid doses only within the prescribed dosing eligibility window.
Locations (1)
Yale New Haven Hospital SRC
New Haven, Connecticut, United States